This trial is testing whether the over-the-counter drug N-acetyl cysteine (NAC) can help reduce itching. The study will last for about 2 and a half months, and participants will take NAC or a placebo for a week before switching to the other option.
- Skin Disorder
4 Primary · 0 Secondary · Reporting Duration: 7 days
Side Effects for
2 Treatment Groups
N-acetyl Cysteine then Placebo
1 of 2
Placebo then N-acetyl Cysteine
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: N-acetyl cysteine · Has Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18 - 40 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many volunteer participants are enrolled in this clinical trial?
"Affirmative. Data hosted on clinicaltrials.gov showcases that this medical trial, which was created on June 19th 2022 is conducting recruitment operations. The project necessitates the enrolment of 20 individuals from a single site." - Anonymous Online Contributor
Are there any openings for prospective participants in this research project?
"The trial is currently seeking participants, as indicated by the data on clinicaltrials.gov. This study was initially posted in June of 2022 and has since been updated in September of that same year." - Anonymous Online Contributor
Is there an age limit for patients involved in this research endeavor?
"This medical research trial is open to adults aged 18-40. For those under 18 and over 65, there are 16 and 61 alternative trials respectively." - Anonymous Online Contributor
What are the eligibility requirements for participating in this clinical research?
"Eligibility requirements for this medical trial mandate that potential participants be between 18 and 40 years old, with the symptom of pruritus. The study's investigators are seeking 20 patients in total." - Anonymous Online Contributor